Brazil’s analytical method of validation of pharmaceutical ingredients:

The Brazilian Health Regulatory Agency ( ANVISA) has issued Draft Technical Resolution no. 129, 12 February 2016, regarding analytical methods validation on biological, microbiological, immunological, identification, impurity determination quantitative trials; impurity control limit trials, quantitative trials to pharmaceutical ingredients in raw material and medicines in every phase of production.

If the Proposal/Notification/Regulation will affect your International Business please send us your representation with facts and figures, so that these can be taken up suitably.